Search
Now showing items 11-20 of 135
Exogenous testosterone (T) alone or with finasteride increases physical performance, grip strength, and lean body mass in older men with low serum T
(Endocrine Society, 2005-03)
Testosterone (T) therapy in older men with low serum T levels increases
lean body mass and decreases fat mass. These changes might improve
physical performance and strength; however, it has not been established
whether T therapy improves functional outcome in older men. Moreover,
concerns exist ...
Reproductive ageing and ovarian function: is the early follicular phase FSH rise necessary to maintain adequate secretory function in older ovulatory women?
(Oxford University Press, 2005-01)
BACKGROUND: Serum FSH elevations and decreases in inhibin B have been
consistently demonstrated in the early follicular phase of cycles in women
of advanced reproductive age. However, secretory products of the dominant
follicle (estradiol and inhibin A) in the serum of older ovulatory women
are ...
Daily testosterone and gonadotropin levels are similar in azoospermic and nonazoospermic normal men administered weekly testosterone: implications for male contraceptive development
(American Society of Andrology, 2001-11)
Weekly intramuscular administration of testosterone esters such as
testosterone enanthate (TE) suppresses gonadotropins and spermatogenesis
and has been studied as a male contraceptive. For unknown reasons,
however, some men fail to achieve azoospermia with such regimens. We
hypothesized that either ...
The effects of aging in normal men on bioavailable testosterone and luteinizing hormone secretion: response to clomiphene citrate
(Endocrine Society, 1987-12)
Serum testosterone (T) levels in men decline with age while serum LH
levels, as measured by RIA, increase. To assess if the decline in serum T
levels in healthy aging men is paralleled by an age-related decline in the
bioavailable non-sex hormone-binding globulin (SHBG)-bound fraction of T
and to ...
The anterior pituitary response to a gonadotropin-releasing hormone challenge test in normal older reproductive-age women
(Elsevier, 1996-03)
OBJECTIVE: To assess the pituitary responsiveness to GnRH stimulation of
premenopausal women relative to age. DESIGN: Older and younger
reproductive-age women underwent the GnRH stimulation test in the early
follicular phase of the menstrual cycle. SETTING: Female subjects in an
academic research ...
Effects of aging on menstrual cycle hormones and endometrial maturation
(Elsevier, 1995-09)
OBJECTIVE: To investigate changes in menstrual cycle hormones and
endometrial maturation that may contribute to the decline in fertility
with aging. DESIGN: Prospective controlled clinical study. SETTING: Normal
human volunteers in an academic research institution. SUBJECTS: Women with
regular ...
Abnormal patterns of pulsatile luteinizing hormone in women with luteal phase deficiency
(Elsevier, 1984-05)
Luteal phase deficiency is usually a problem of inadequate progesterone
production associated with inadequate ovarian follicular development. The
hypothesis that luteal phase deficiency results from an abnormal secretion
pattern of luteinizing hormone (LH) was tested in these women. To this
end, ...
Decreased serum inhibin levels in normal elderly men: evidence for a decline in Sertoli cell function with aging
(Endocrine Society, 1988-09)
Compared to young men, normal elderly men have decreased sperm production
despite elevated serum gonadotropin levels. To determine whether the
seminiferous tubule defect in elderly men includes decreased Sertoli cell
function, we measured serum immunoreactive inhibin concentrations in young
and ...
The importance of luteinizing hormone in the control of inhibin and progesterone secretion by the human corpus luteum
(Endocrine Society, 1989-06)
Serum inhibin levels rise markedly during the luteal phase of the human
menstrual cycle and are closely correlated with serum progesterone (P)
levels, suggesting that the corpus luteum (CL) secretes inhibin. While FSH
is the major regulator of inhibin secretion by the granulosa cells, the
control ...
Acyline: the first study in humans of a potent, new gonadotropin-releasing hormone antagonist
(Endocrine Society, 2002-07)
Acyline is a novel GnRH antagonist found in animal studies to be a potent
suppressor of circulating gonadotropin and testosterone (T) levels. We
conducted the first study of acyline administration to humans. Eight
healthy, eugonadal young men were administered a series of acyline
injections (0, ...